Genomics in Drug Discovery and Development by Dimitri Semizarov
Look inside with Google Book Preview
Genomics in Drug Discovery and Development
By Dimitri Semizarov

Genomics in Drug Discovery and Development

By (author) See other recent books by Dimitri Semizarov See other recent books by Eric Blomme
Format: Hardback

Normal Price: $228.95
Your Price: $206.06 AUD, inc. GST
Shipping: $7.95 per order
You Save: $22.89! (10% off normal price)
Plus...earn $10.30 in Boomerang Bucks
Availability: Available Available to Backorder, No Due Date for Supply

Genomics in Drug Discovery and Development by Dimitri Semizarov

Book Description

Early characterization of toxicity and efficacy would significantly impact the overall productivity of pharmaceutical R&D and reduce drug candidate attrition and failure. By describing the available platforms and weighing their relative advantages and disadvantages, including microarray data analysis, Genomics in Drug Discovery and Development introduces readers to the biomarker, pharmacogenomic, and toxicogenomics toolbox. The authors provide a valuable resource for pharmaceutical discovery scientists, preclinical drug safety department personnel, regulatory personnel, discovery toxicologists, and safety scientists, drug development professionals, and pharmaceutical scientists.

Buy Genomics in Drug Discovery and Development book by Dimitri Semizarov from Australia's Online Bookstore, Boomerang Books.

Book Details

ISBN: 9780470096048
ISBN-10: 0470096047
Format: Hardback
(236mm x 163mm x 28mm)
Pages: 480
Imprint: Wiley-Blackwell
Publisher: John Wiley and Sons Ltd
Publish Date: 13-Nov-2008
Country of Publication: United States


» Have you read this book? We'd like to know what you think about it - write a review about Genomics in Drug Discovery and Development book by Dimitri Semizarov and you'll earn 50c in Boomerang Bucks loyalty dollars (you must be a member - it's free to sign up!)

Write a book review

Author Biography - Dimitri Semizarov

Dimitri Semizarov, PhD , is a Senior Group Leader in the Cancer Research Department of Abbott Laboratories' Global Pharmaceutical R&D. Dr. Semizarov leads cancer genomics research at Abbott, applying genomics technologies to enable personalization of cancer therapy. He is author or coauthor of more than twenty scientific articles and eight patent applications, as well as three book chapters (including two chapters in Wiley's Preclinical Development Handbook). Eric Blomme, DVM, PhD , Diplomate, American College of Veterinary Pathologists, is a Senior Project Leader for Cellular, Molecular, and Exploratory Toxicology in Global Pharmaceutical R&D at Abbott Laboratories. He has extensive drug discovery, toxicology, and screening experience working for Abbott, Pharmacia, Monsanto, Searle, Ohio State University, and Cornell University. Dr. Blomme has written over fifty journal articles and eight book chapters, and is a reviewer for multiple scientific journals in the fields of toxicology and pathology.

Boomerang Bucks close

For every $20 you spend on books, you will receive $1 in Boomerang Bucks loyalty dollars. You can use your Boomerang Bucks as a credit towards a future purchase from Boomerang Books. Note that you must be a Member (free to sign up) and that conditions do apply.

Recent books by Dimitri Semizarov close
Recent books by Eric Blomme close
Genomics in Drug Discovery and Development by Eric Blomme
» close